Work

Histone deacetylase inhibitor LAQ824 down-regulates Her-2 and sensitizes human breast cancer cells to trastuzumab, taxotere, gemcitabine, and epothilone B.

FWCI: 6.223
Cites: 62
Cited by: 261
Related to: 10